文献
J-GLOBAL ID:201802240626771849
整理番号:18A0270085
局所進行した非小細胞肺癌の第一選択療法としてのゲフィチニブを用いたメトホルミンの多施設二重盲検第II相試験【Powered by NICT】
A Multicenter Double-blind Phase II Study of Metformin With Gefitinib as First-line Therapy of Locally Advanced Non-Small-cell Lung Cancer
著者 (7件):
Li Kun-lin
(Department of Respiration, Daping Hospital, Third Military Medical University, P.R. China)
,
Li Li
(Department of Respiration, Daping Hospital, Third Military Medical University, P.R. China)
,
Zhang Peng
(Sichuan International Studies University, P.R. China)
,
Kang Jun
(Department of Respiration, Daping Hospital, Third Military Medical University, P.R. China)
,
Wang Yu-bo
(Department of Respiration, Daping Hospital, Third Military Medical University, P.R. China)
,
Chen Heng-yi
(Department of Respiration, Daping Hospital, Third Military Medical University, P.R. China)
,
He Yong
(Department of Respiration, Daping Hospital, Third Military Medical University, P.R. China)
資料名:
Clinical Lung Cancer
(Clinical Lung Cancer)
巻:
18
号:
3
ページ:
340-343
発行年:
2017年
JST資料番号:
W3210A
ISSN:
1525-7304
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)